220 related articles for article (PubMed ID: 33297779)
21. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.
Jung JW; Han SJ; Song MK; Kim TI; Kim EK; Min YH; Cheong JW; Seo KY
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2079-2085. PubMed ID: 26303101
[TBL] [Abstract][Full Text] [Related]
22. Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Prenc E; Pulanic D; Pucic-Bakovic M; Pezer M; Desnica L; Vrhovac R; Nemet D; Pavletic SZ
Biochim Biophys Acta; 2016 Aug; 1860(8):1615-22. PubMed ID: 26923767
[TBL] [Abstract][Full Text] [Related]
23. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
Rapoport Y; Freeman T; Koyama T; Engelhardt BG; Jagasia M; Savani BN; Tran U; Kassim AA
Cornea; 2017 Feb; 36(2):258-263. PubMed ID: 28060078
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-host disease.
Moreno DF; Cid J
Med Clin (Barc); 2019 Jan; 152(1):22-28. PubMed ID: 30309668
[TBL] [Abstract][Full Text] [Related]
25. Clinical update on graft-versus-host disease in children.
Goddard DS; Horn BN; McCalmont TH; Cordoro KM
Semin Cutan Med Surg; 2010 Jun; 29(2):92-105. PubMed ID: 20579598
[TBL] [Abstract][Full Text] [Related]
26. The role of biomarkers in risk stratification, treatment and outcome in acute GVHD.
Kaviany S; Kitko CL
Curr Opin Hematol; 2021 Nov; 28(6):401-407. PubMed ID: 34475350
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
[TBL] [Abstract][Full Text] [Related]
28. Life-threatening graft-vs-host disease.
Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
[TBL] [Abstract][Full Text] [Related]
29. Noncoding RNAs in diagnosis and prognosis of graft-versus-host disease (GVHD).
Vajari MK; Moradinasab S; Yousefi AM; Bashash D
J Cell Physiol; 2022 Sep; 237(9):3480-3495. PubMed ID: 35842836
[TBL] [Abstract][Full Text] [Related]
30. Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.
Dander E; De Lorenzo P; Bottazzi B; Quarello P; Vinci P; Balduzzi A; Masciocchi F; Bonanomi S; Cappuzzello C; Prunotto G; Pavan F; Pasqualini F; Sironi M; Cuccovillo I; Leone R; Salvatori G; Parma M; Terruzzi E; Pagni F; Locatelli F; Mantovani A; Fagioli F; Biondi A; Garlanda C; Valsecchi MG; Rovelli A; D'Amico G
Oncotarget; 2016 Dec; 7(50):82123-82138. PubMed ID: 27893415
[TBL] [Abstract][Full Text] [Related]
31. NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment scheme.
Zhang P; Yang S; Zou Y; Yan X; Wu H; Zhou M; Sun YC; Zhang Y; Zhu H; Xu K; Wang Y; Sheng LX; Mu Q; Sun L; Ouyang G
BMC Immunol; 2019 Dec; 20(1):46. PubMed ID: 31818250
[TBL] [Abstract][Full Text] [Related]
32. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
Zeiser R; Blazar BR
Blood; 2016 Jun; 127(25):3117-26. PubMed ID: 26994149
[TBL] [Abstract][Full Text] [Related]
33. Systemic biomarkers of allogeneic haematopoietic stem cell transplantation outcome-Brief introduction.
Mrazek F
HLA; 2019 Dec; 94 Suppl 2():25-29. PubMed ID: 31729192
[TBL] [Abstract][Full Text] [Related]
34. The role of regulatory T cells in graft-versus-host disease management.
Whangbo JS; Antin JH; Koreth J
Expert Rev Hematol; 2020 Feb; 13(2):141-154. PubMed ID: 31874061
[No Abstract] [Full Text] [Related]
35. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
36. Elafin as a Predictive Biomarker of Acute Skin Graft-
Solán L; Carbonell D; Muñiz P; Dorado N; Landete E; Chicano-Lavilla M; Anguita J; Gayoso J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2021; 12():516078. PubMed ID: 33679728
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
Ringdén O; Gustafsson B; Sadeghi B
Front Immunol; 2020; 11():567210. PubMed ID: 33193339
[TBL] [Abstract][Full Text] [Related]
38. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
39. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.
Noor F; Kaysen A; Wilmes P; Schneider JG
J Innate Immun; 2019; 11(5):405-415. PubMed ID: 30286447
[TBL] [Abstract][Full Text] [Related]
40. Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease.
Shimizu E; Ogawa Y; Saijo Y; Yamane M; Uchino M; Kamoi M; Fukui M; Yang F; He J; Mukai S; Tsubota K
Ocul Surf; 2019 Apr; 17(2):265-271. PubMed ID: 30742990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]